Balchem Past Earnings Performance
Past criteria checks 5/6
Balchem has been growing earnings at an average annual rate of 9.7%, while the Chemicals industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 7.2% per year. Balchem's return on equity is 11.3%, and it has net margins of 14.5%.
Key information
9.72%
Earnings growth rate
9.61%
EPS growth rate
| Chemicals Industry Growth | 12.93% |
| Revenue growth rate | 7.25% |
| Return on equity | 11.26% |
| Net Margin | 14.48% |
| Last Earnings Update | 30 Jun 2025 |
Recent past performance updates
Recent updates
Balchem (NASDAQ:BCPC) Could Easily Take On More Debt
Sep 26
Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Aug 26Balchem (NASDAQ:BCPC) Is Looking To Continue Growing Its Returns On Capital
Jul 21Balchem Corporation: The Next Earnings Release Should Guide Investors
Jul 14These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely
Jun 23When Should You Buy Balchem Corporation (NASDAQ:BCPC)?
May 26Estimating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
May 12Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?
Apr 17We Think Balchem (NASDAQ:BCPC) Can Manage Its Debt With Ease
Mar 21Balchem Corporation (NASDAQ:BCPC) Not Lagging Market On Growth Or Pricing
Mar 07A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
Jan 30Is Balchem (NASDAQ:BCPC) A Risky Investment?
Dec 19If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity
Dec 06Balchem Corporation's (NASDAQ:BCPC) Earnings Haven't Escaped The Attention Of Investors
Nov 22Balchem's Q3 Shows Record Earnings And Valuation Pressure
Oct 28Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return
Oct 21Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Oct 07Is Balchem (NASDAQ:BCPC) Using Too Much Debt?
Sep 09
Innovating In Nutrition And Health Sectors Drives Strong Financial Growth And Market Expansion
Launch of Optifolin+ in the nutrition segment and strong Human Nutrition & Health sales indicate potential for market share expansion and sustained revenue growth.Here's Why We Think Balchem (NASDAQ:BCPC) Might Deserve Your Attention Today
Aug 27Balchem Corporation's (NASDAQ:BCPC) Shares May Have Run Too Fast Too Soon
Aug 13Earnings Update: Here's Why Analysts Just Lifted Their Balchem Corporation (NASDAQ:BCPC) Price Target To US$184
Jul 31Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing
Jun 29Shareholders Will Most Likely Find Balchem Corporation's (NASDAQ:BCPC) CEO Compensation Acceptable
Jun 15Calculating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
Jun 10Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching
May 26Balchem: A Tale Of Two Businesses
May 10Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear
Mar 21Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value
Mar 05Balchem: Potential Turnaround Is In The Price
Feb 21These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well
Feb 18Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled
Jan 03Balchem Corporation's (NASDAQ:BCPC) P/E Is On The Mark
Dec 19Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Nov 20Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet
Oct 19The Returns At Balchem (NASDAQ:BCPC) Aren't Growing
Sep 09A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
Aug 22Is Balchem (NASDAQ:BCPC) A Risky Investment?
Jul 19Some Investors May Be Worried About Balchem's (NASDAQ:BCPC) Returns On Capital
May 28Calculating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
May 12Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?
Apr 12We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt
Mar 14Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns
Jan 11Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching
Dec 29Is Balchem (NASDAQ:BCPC) A Risky Investment?
Dec 13Balchem Corporation (NASDAQ:BCPC) Shares Could Be 26% Above Their Intrinsic Value Estimate
Nov 29Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return
Sep 20Balchem: Acquisitions And Cost Pressures Draw Attention
Sep 12Revenue & Expenses Breakdown
How Balchem makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 25 | 986 | 143 | 136 | 18 |
| 31 Mar 25 | 965 | 137 | 132 | 17 |
| 31 Dec 24 | 954 | 128 | 135 | 17 |
| 30 Sep 24 | 942 | 122 | 144 | 16 |
| 30 Jun 24 | 932 | 117 | 139 | 16 |
| 31 Mar 24 | 930 | 115 | 131 | 16 |
| 31 Dec 23 | 922 | 109 | 130 | 15 |
| 30 Sep 23 | 926 | 103 | 117 | 14 |
| 30 Jun 23 | 941 | 99 | 122 | 13 |
| 31 Mar 23 | 946 | 99 | 126 | 12 |
| 31 Dec 22 | 942 | 105 | 121 | 12 |
| 30 Sep 22 | 923 | 109 | 116 | 14 |
| 30 Jun 22 | 877 | 109 | 109 | 14 |
| 31 Mar 22 | 842 | 102 | 107 | 14 |
| 31 Dec 21 | 799 | 96 | 102 | 14 |
| 30 Sep 21 | 767 | 93 | 100 | 11 |
| 30 Jun 21 | 744 | 90 | 100 | 11 |
| 31 Mar 21 | 715 | 88 | 99 | 10 |
| 31 Dec 20 | 704 | 85 | 102 | 10 |
| 30 Sep 20 | 689 | 83 | 104 | 11 |
| 30 Jun 20 | 673 | 82 | 104 | 11 |
| 31 Mar 20 | 661 | 81 | 102 | 11 |
| 31 Dec 19 | 644 | 80 | 95 | 11 |
| 30 Sep 19 | 641 | 80 | 89 | 12 |
| 30 Jun 19 | 637 | 78 | 84 | 12 |
| 31 Mar 19 | 639 | 78 | 82 | 12 |
| 31 Dec 18 | 644 | 79 | 84 | 12 |
| 30 Sep 18 | 639 | 100 | 83 | 11 |
| 30 Jun 18 | 635 | 97 | 84 | 11 |
| 31 Mar 18 | 618 | 94 | 81 | 10 |
| 31 Dec 17 | 595 | 90 | 81 | 9 |
| 30 Sep 17 | 576 | 64 | 82 | 9 |
| 30 Jun 17 | 564 | 62 | 82 | 8 |
| 31 Mar 17 | 556 | 60 | 82 | 7 |
| 31 Dec 16 | 553 | 56 | 83 | 7 |
| 30 Sep 16 | 545 | 56 | 77 | 7 |
| 30 Jun 16 | 547 | 56 | 76 | 7 |
| 31 Mar 16 | 543 | 56 | 72 | 6 |
| 31 Dec 15 | 552 | 60 | 68 | 6 |
| 30 Sep 15 | 582 | 63 | 71 | 6 |
| 30 Jun 15 | 603 | 64 | 70 | 6 |
| 31 Mar 15 | 600 | 59 | 68 | 5 |
| 31 Dec 14 | 541 | 53 | 57 | 5 |
Quality Earnings: BCPC has high quality earnings.
Growing Profit Margin: BCPC's current net profit margins (14.5%) are higher than last year (12.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BCPC's earnings have grown by 9.7% per year over the past 5 years.
Accelerating Growth: BCPC's earnings growth over the past year (22.2%) exceeds its 5-year average (9.7% per year).
Earnings vs Industry: BCPC earnings growth over the past year (22.2%) exceeded the Chemicals industry 3.7%.
Return on Equity
High ROE: BCPC's Return on Equity (11.3%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/05 00:48 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Balchem Corporation is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Labick | CJS Securities, Inc. |
| Timothy Ramey | D.A. Davidson & Co. |
| Raghuram Selvaraju | H.C. Wainwright & Co. |